These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. No adverse effects in infants following short-course zidovudine. AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279877 [No Abstract] [Full Text] [Related]
13. Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudine. Foli A; Lori F; Maserati R; Tinelli C; Minoli L; Lisziewicz J Antivir Ther; 1997 Jan; 2(1):31-8. PubMed ID: 11322264 [TBL] [Abstract][Full Text] [Related]
14. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients. Gartland M; Antivir Ther; 2001 Jun; 6(2):127-34. PubMed ID: 11491417 [TBL] [Abstract][Full Text] [Related]
15. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection. Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023 [No Abstract] [Full Text] [Related]
16. Drug research shows easier dosing, new combinations are making gains. AIDS Alert; 1998 Apr; 13(4):37-9. PubMed ID: 11365139 [TBL] [Abstract][Full Text] [Related]
17. [Severe anemia in the framework of zidovudine treatment in HIV disease]. Kis L; Heitzmann F; Keusch G; Möddel M Praxis (Bern 1994); 2006 Jan; 95(4):119-22. PubMed ID: 16485608 [No Abstract] [Full Text] [Related]
18. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538 [TBL] [Abstract][Full Text] [Related]
19. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990 [TBL] [Abstract][Full Text] [Related]
20. The role of zidovudine in development of lipoatrophy. Moyle GJ AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181 [No Abstract] [Full Text] [Related] [Next] [New Search]